Susquehanna International Group
NRXPW

Susquehanna International Group’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Susquehanna International Group’s Portfolio NRXPW Stock Details NRXPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,412
Closed -$669 – 13817
2025
Q4 		$669 Sell
11,412
-30,755
-73% -$3.07K ﹤0.01% 12162
2025
Q3 		$3.37K Buy
+42,167
New +$3.58K ﹤0.01% 12148
2024
Q2 		– Sell
-13,436
Closed -$2.42K – 12862
2024
Q1 		$2.42K Buy
+13,436
New +$1.97K ﹤0.01% 11980
2022
Q3 		– Sell
-15,678
Closed -$2K – 13827
2022
Q2 		$2K Buy
+15,678
New +$7.68K ﹤0.01% 12688
2020
Q2 		– Sell
-21,017
Closed -$1K – 10657
2020
Q1 		$1K Sell
21,017
-9,610
-31% -$1.16K ﹤0.01% 10136
2019
Q4 		$5K Buy
30,627
+1,000
+3% +$182 ﹤0.01% 9577
2019
Q3 		$5K Hold
29,627
– – ﹤0.01% 10047
2019
Q2 		$7K Buy
29,627
+1,459
+5% +$258 ﹤0.01% 10093
2019
Q1 		$5K Hold
28,168
– – ﹤0.01% 8677
2018
Q4 		$11K Buy
+28,168
New +$9.76K ﹤0.01% 8737

Other funds holding NRXPW

WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Susquehanna International Group's NRXPW Position: Q1 2026 in Review

Susquehanna International Group sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q1 2026, closing a stake of 11,412 shares — an estimated $669 sold.

Susquehanna International Group first reported a position in NRXPW in Q4 2018 and held it in 10 quarters. The position peaked at $11K in Q4 2018. 2 funds tracked by Wall St. Rank hold NRXPW as of Q1 2026.

  • Susquehanna International Group reported no remaining NRX Pharmaceuticals Warrant position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 11,412 NRX Pharmaceuticals Warrant shares in Q1 2026, an estimated $669.
  • Susquehanna International Group first reported a position in NRX Pharmaceuticals Warrant in Q4 2018 and held it in 10 quarters.
  • Susquehanna International Group's NRX Pharmaceuticals Warrant position peaked at $11K in Q4 2018.
  • 2 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.